Capital Investment Advisors LLC Buys 1,759 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Capital Investment Advisors LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,714 shares of the healthcare conglomerate’s stock after acquiring an additional 1,759 shares during the period. Capital Investment Advisors LLC’s holdings in UnitedHealth Group were worth $13,280,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Blue Trust Inc. grew its position in UnitedHealth Group by 49.0% in the third quarter. Blue Trust Inc. now owns 10,429 shares of the healthcare conglomerate’s stock valued at $6,098,000 after acquiring an additional 3,429 shares during the last quarter. Meridian Financial Partners LLC grew its position in UnitedHealth Group by 1.9% in the third quarter. Meridian Financial Partners LLC now owns 2,902 shares of the healthcare conglomerate’s stock valued at $1,697,000 after acquiring an additional 54 shares during the last quarter. IFG Advisors LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth about $223,000. Moss Adams Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group by 10.0% during the third quarter. Moss Adams Wealth Advisors LLC now owns 4,320 shares of the healthcare conglomerate’s stock worth $2,526,000 after purchasing an additional 394 shares during the last quarter. Finally, KMG Fiduciary Partners LLC grew its holdings in shares of UnitedHealth Group by 0.5% during the third quarter. KMG Fiduciary Partners LLC now owns 13,952 shares of the healthcare conglomerate’s stock worth $8,158,000 after purchasing an additional 75 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on UNH. Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday. Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday. UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.58.

View Our Latest Research Report on UNH

UnitedHealth Group Trading Up 0.6 %

NYSE UNH opened at $569.61 on Friday. The company has a market cap of $525.99 billion, a price-to-earnings ratio of 37.77, a P/E/G ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The business has a 50 day moving average price of $584.42 and a 200-day moving average price of $533.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).